Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 125K 116K 108K 203K 13.53M 205K 1.37M 532K 6.66M 538K 527K 23.12M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.01M 18.53M 17.35M 32.53M 2.17B 32.73M 220M 85.2M 1.07B 86.14M 84.29M 3.7B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.22% | -2.32% | +18.35% | -13.53% | 173B | ||
| +15.64% | -1.48% | -20.16% | +23.51% | 144B | ||
| -1.87% | -2.00% | -8.88% | -26.73% | 125B | ||
| +1.71% | -3.99% | -55.32% | -16.62% | 67.32B | ||
| -0.10% | +1.87% | +18.09% | -4.98% | 50.3B | ||
| -0.58% | -1.16% | -25.42% | -34.65% | 44.09B | ||
| +2.20% | -1.92% | +9.99% | +4.90% | 35.89B | ||
| -0.44% | -1.20% | +4.74% | +32.04% | 34.9B | ||
| +9.82% | -4.53% | -14.33% | -21.69% | 28.02B | ||
| Average | +0.53% | -2.12% | -8.11% | -6.42% | 78.07B | |
| Weighted average by Cap. | +0.54% | -2.00% | -6.64% | -6.42% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.51M 1.4M 1.31M 2.45M 163M 2.47M 16.57M 6.42M 80.32M 6.49M 6.35M 279M | 1.98M 1.72M 1.6M 1.5M 2.8M 187M 2.82M 18.95M 7.34M 91.86M 7.42M 7.26M 319M |
| Net income | -16.08M -14.02M -12.98M -12.15M -22.79M -1.52B -22.93M -154M -59.69M -747M -60.35M -59.05M -2.59B | -29.31M -25.56M -23.67M -22.16M -41.56M -2.77B -41.81M -281M -109M -1.36B -110M -108M -4.73B |
| Net Debt | 20.53M 17.9M 16.57M 15.52M 29.1M 1.94B 29.28M 197M 76.21M 953M 77.05M 75.4M 3.31B | 22.8M 19.88M 18.42M 17.24M 32.33M 2.15B 32.53M 218M 84.67M 1.06B 85.6M 83.77M 3.68B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















